|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao S, Yao D, Chen J, Ding N and Ren F:
MiR-20a promotes cervical cancer proliferation and metastasis in
vitro and in vivo. PLoS One. 10:e01209052015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Handler AS, Henderson VA, Rosenfeld A,
Rankin K, Jones B and Issel LM: Illinois breast and cervical cancer
program: Implementing effective public-private partnerships to
assure population health. J Public Health Manag Pract. 21:459–466.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wen Z, Lei Z, Jin-An M, Xue-Zhen L,
Xing-Nan Z and Xiu-Wen D: The inhibitory role of miR-214 in
cervical cancer cells through directly targeting mitochondrial
transcription factor A (TFAM). Eur J Gynaecol Oncol. 35:676–682.
2014.PubMed/NCBI
|
|
5
|
Xu J, Zhang W, Lv Q and Zhu D:
Overexpression of miR-21 promotes the proliferation and migration
of cervical cancer cells via the inhibition of PTEN. Oncol Rep.
33:3108–3116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Y, Ma C, Zhang W, Chen Z and Ma L:
Down regulation of miR-143 is related with tumor size, lymph node
metastasis and HPV16 infection in cervical squamous cancer. Diagn
Pathol. 9:882014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Q, Qin J, Chen A, Zhou J, Liu J,
Cheng J, Qiu J and Zhang J: Downregulation of microRNA-145 is
associated with aggressive progression and poor prognosis in human
cervical cancer. Tumour Biol. 36:3703–3708. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang YK, Xi WY, Xi RX, Li JY, Li Q and Gao
YE: MicroRNA-494 promotes cervical cancer proliferation through the
regulation of PTEN. Oncol Rep. 33:2393–2401. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan J, Wang K and Xi M: MiR-494 inhibits
epithelial ovarian cancer growth by targeting c-Myc. Med Sci Monit.
22:617–624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
FIGO staging for carcinoma of the vulva,
cervix and corpus uteri, . International journal of gynaecology and
obstetrics: The official organ of the International Federation of
Gynaecology and Obstetrics. 125:1–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou RP, Chen G, Shen ZL and Pan LQ:
Cinobufacin suppresses cell proliferation via miR-494 in BGC-823
gastric cancer cells. Asian Pac J Cancer Prev. 15:1241–1245. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zou Ruanmin, Hu Zhi, Chen Hao, et al:
MiR199a in cervical cancer and cervical intraepithelial lesions
Expression and significance. J Med Res. 40:55–59. 2011.
|
|
13
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sharma G, Dua P and Agarwal SM: A
comprehensive review of dysregulated miRNAs involved in cervical
cancer. Curr Genomics. 15:310–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Villegas-Ruiz V, Juárez-Méndez S,
Pérez-González OA, Arreola H, Paniagua-García L, Parra-Melquiadez
M, Peralta-Rodríguez R, López-Romero R, Monroy-García A,
Mantilla-Morales A, et al: Heterogeneity of microRNAs expression in
cervical cancer cells: Over-expression of miR-196a. Int J Clin Exp
Pathol. 7:1389–1401. 2014.PubMed/NCBI
|
|
17
|
Zhao Q, Zhai YX, Liu HQ, Shi YA and Li XB:
MicroRNA-491-5p suppresses cervical cancer cell growth by targeting
hTERT. Oncol Rep. 34:979–986. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deng B, Zhang Y, Zhang S, Wen F, Miao Y
and Guo K: MicroRNA-142-3p inhibits cell proliferation and invasion
of cervical cancer cells by targeting FZD7. Tumour Biol.
36:8065–8073. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li XT, Wang HZ, Wu ZW, Yang TQ, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Huang YL, et al: miR-494-3p
regulates cellular proliferation, invasion, migration, and
apoptosis by PTEN/AKT signaling in human glioblastoma cells. Cell
Mol Neurobiol. 35:679–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun HB, Chen X, Ji H, Wu T, Lu HW, Zhang
Y, Li H and Li YM: miR-494 is an independent prognostic factor and
promotes cell migration and invasion in colorectal cancer by
directly targeting PTEN. Int J Oncol. 45:2486–2494. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song L, Liu D, Wang B, He J, Zhang S, Dai
Z, Ma X and Wang X: miR-494 suppresses the progression of breast
cancer in vitro by targeting CXCR4 through the Wnt/β-catenin
signaling pathway. Oncol Rep. 34:525–531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang Y, Sun B, Xiang J and Chen Z:
MiR-301a promotes colorectal cancer cell growth and invasion by
directly targeting SOCS6. Cell Physiol Biochem. 35:227–236. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tanaka T, Arai M, Jiang X, Sugaya S, Kanda
T, Fujii K, Kita K, Sugita K, Imazeki F, Miyashita T, et al:
Downregulation of microRNA-431 by human interferon-β inhibits
viability of medulloblastoma and glioblastoma cells via
upregulation of SOCS6. Int J Oncol. 44:1685–1690. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu Q, Luo G, Yang Z, Zhu F, An Y, Shi Y
and Fan D: miR-17-5p promotes proliferation by targeting SOCS6 in
gastric cancer cells. FEBS Lett. 588:2055–2062. 2014. View Article : Google Scholar : PubMed/NCBI
|
